Investors can consider this company with a 3 year horizon. Its earnings performance is dependent upon timely approvals of products in its pipeline, says Akash Jain of Ajcon Global.
Investors need to be careful while selecting stocks in midcap space as any unfavourable result in state elections would result in a drastic fall in midcaps and smallcaps
Reversal of the bearish view can be pegged above the recent high of 10,929, says Gaurav Ratnaparkhi of Sharekhan
Global brokerage house Citi expects double digit growth for current financial year (FY19) but with some downgrade risks.
Nomura has initiated coverage with Buy call on Tejas Networks and set a target price at Rs 430 per share.
Manav Chopra of Indiabulls Ventures advises buying Titan Company with a target of Rs 925.
GSPL, Cipla and Bharti Airtel, among others, are being tracked by investors on Wednesday.
Mitessh Thakkar of miteshthacker.com advises selling Arvind with a target of Rs 372.
"The index has formed 'Spinning Top' candlestick pattern indicating lack of momentum on either side. Now Nifty has to close above 10,250 marks for further upside. The level 10,400 will work as immediate hurdle zone and support is seen around 10,130 mark," says Rajesh Agarwal of AUM Capital.
Credit Suisse has upgraded Aurobindo to Outperform from Neutral rating with a target price at Rs 750 per share as the stock is attractive for low valuations at 13x FY19 EPS.
Rajat Bose of rajatkbose.com advises buying Sun Pharma.
According to Vijay Chopra of enochventures.com, one may stay with Dr Reddy's Laboratories.
Mitessh Thakkar of miteshthacker.com recommends buying Ashok Leyland, Dr Reddy's Labs and Bharat Forge and advises selling Axis Bank.
Gaurav Ratnaparkhi of Sharekhan advises buying Dr Reddy's Lab with a target of Rs 2283.
Sudarshan Sukhani of s2analytics.com is of the view that one can buy Apollo Hospitals, Escorts and Kotak Mahindra Bank and can avoid Dr Reddy's Labs.
It would be advisable to initiate fresh shorts only below 10300 in the Nifty. Resistance for the same would remain in the range of 10600-10640.
Looking at the weekly chart formed last week, Nifty formed a Bearish Engulfing pattern and the impact of the said pattern was clearly seen in this week.
Sudarshan Sukhani of s2analytics.com advises selling Canara Bank, NMDC and Godfrey Phillips.
Maruti, DRL and UPL, among others, are being tracked by investors on Monday.
Ashwani Gujral of ashwanigujral.com recommends buying Escorts and Mphasis.
Sudarshan Sukhani of s2analytics.com is of the view that one can buy Axis Bank, Dr Reddy's Labs, TCS and Wockhardt and can exit MMTC.
Sameet Chavan of Angel Broking is of the view that one may sell OBC with a target of Rs 110.
Most of the high beta stocks saw strong momentum in the year 2017 and is finding favour in the year 2018 as well. But, will it work every time? Well, analysts are of the view that out-of-favor stocks have beaten the benchmark in the last 10 years.
Investors are better off betting on stocks which can deliver benchmark beating gains.
Credit Suisse has an Outperform rating for Tata Steel with target price at Rs 830 per share and JSW Steel with target at Rs 300, but has a neutral rating for Jindal Steel & Power with target price at Rs 150.